ArticleAdvances in pharmacological and pharmaceutical sciences2025
Antileishmanial Activities of Methanol Extract and Solvent Fraction of
Article in Advances in pharmacological and pharmaceutical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Phytochemical fingerprinting, antioxidant activity and cytotoxic evaluation of marketed Thalictrum foliolosum (Pili Jadi) root against MCF-7 breast cancer cells.Scientific reports · 2026Article
- Antileishmanial Activities of Methanol Extract and Solvent Fraction ofAdvances in pharmacological and pharmaceutical sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Leishmaniasis is a neglected tropical disease affecting 12 million people and risks the lives of 350 million people globally. However, it has limited therapeutic options. Objective: The aim of this study was to evaluate Methods: In vitro antileishmanial activity of crude extract of Result: The crude extract and its hexane, chloroform, and aqueous fractions exhibited antileishmanial activities, with IC Conclusion: The roots of the plant showed a promising antileishmanial activity that may provide a scientific justification for its use in traditional medicine. Further isolation, identification of active compounds, and establishment of the mechanism of action are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.